Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, Schweitzer A, Schnoy E, Atreya R, Teich N, Trentmann L, Ehehalt R, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: hartmann p. Inflamm Bowel Dis. 2024 May 2;30(5):746-756. doi: 10.1093/ibd/izad138. Inflamm Bowel Dis. 2024. PMID: 37523666
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, von der Ohe M, Gauss A, Atreya R, Krause T, Blumenstein I, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: hartmann p. Inflamm Bowel Dis. 2023 Nov 2;29(11):1741-1750. doi: 10.1093/ibd/izac271. Inflamm Bowel Dis. 2023. PMID: 36633301
Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5-year follow-up data from the prospective BioCrohn study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Helwig U, Teich N, Schmidt C, Hartmann P, Sobotzki C, Schreiber S. Bokemeyer B, et al. Among authors: hartmann p. Aliment Pharmacol Ther. 2023 Jul;58(1):35-47. doi: 10.1111/apt.17512. Epub 2023 Apr 13. Aliment Pharmacol Ther. 2023. PMID: 37051808
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Krause T, Hoffstadt M, Ehehalt R, Trentmann L, Schweitzer A, Jessen P, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: hartmann p. Aliment Pharmacol Ther. 2023 Aug;58(4):429-442. doi: 10.1111/apt.17616. Epub 2023 Jun 15. Aliment Pharmacol Ther. 2023. PMID: 37322825
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009.
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2023 Aug;61(8):1046-1134. doi: 10.1055/a-2060-0935. Epub 2023 Aug 14. Z Gastroenterol. 2023. PMID: 37579791 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2).
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators. Kucharzik T, et al. Z Gastroenterol. 2024 May;62(5):769-858. doi: 10.1055/a-2271-0994. Epub 2024 May 8. Z Gastroenterol. 2024. PMID: 38718808 Free article. German. No abstract available.
Bird Fauna Composition in a Protected Area in Southern Brazil.
Betiol CFMF, Hartmann MT, Hartmann PA. Betiol CFMF, et al. Among authors: hartmann pa. Zool Stud. 2023 Dec 13;62:e55. doi: 10.6620/ZS.2023.62-55. eCollection 2023. Zool Stud. 2023. PMID: 38628159 Free PMC article.
Camera trap surveys of Atlantic Forest mammals: A data set for analyses considering imperfect detection (2004-2020).
Franceschi IC, Dornas RADP, Lermen IS, Coelho AVP, Vilas Boas AH, Chiarello AG, Paglia AP, de Souza AC, Borsekowsky AR, Rocha A, Bager A, de Souza AZ, Lopes AMC, de Moura AS, Ferreira AS, García-Olaechea A, Delciellos AC, Bacellar AEF, Campelo AKN, Paschoal AMO, Rolim AC, da Silva ALF, Lanna AM, da Silva AP, Guimarães A, Cardoso Â, Cassol AS, da Costa-Pinto AL, do Nascimento AGS, Fernandes AS, Clyvia A, Santos ABD, Lima-Silva B, Beisiegel BM, Luciano BFL, Leopoldo BF, Krobel BN, Kubiak BB, Saranholi BH, Correa BS, Sant Anna Teixeira C, Ayroza CR, Cassano CR, Benitez-Riveros C, Gestich CC, Tedesco CD, Gheler-Costa C, Hegel CGZ, Evangelista Junior CDS, Ferreira CEMF, Grelle CEV, Esteves CF, Espinosa CDC, Leuchtenberger C, Sanchéz-Lalinde C, Machado CIC, Andreazzi C, Bueno C, Cronemberger de Faria C, Novaes C, Widmer CE, Santos CC, Ferraz DDS, Galiano D, Bôlla DAS, Behs D, Rodrigues DP, de Melo DP, Ramos DMS, de Mattia DL, Pavei DD, Loretto D, Huning DDS, Dias DM, Paetzhold ÉR, Rios E, Setz EZF, Cazetta E, Cafofo Silva EG, Pasa E, Saito EN, de Aguiar EFS, Castro ÉP, Viveiros de Castro EB, Pedó E, Pereira FA, Bolzan F, Roque FO, Mazim FD, Comin FH, Maffei F, Peters FB, Fantacini FM, d… See abstract for full author list ➔ Franceschi IC, et al. Among authors: hartmann pa. Ecology. 2024 May;105(5):e4298. doi: 10.1002/ecy.4298. Epub 2024 Apr 12. Ecology. 2024. PMID: 38610092
700 results